NADIA MCFARLANE

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry KATY, TX NPI 1619175239

General Payments — all program years on this page

$1,460.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $408.72 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $408.7220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $65.363
2019 $48.203
2021 $50.831
2022 $271.0814
2023 $615.8830
2024 $408.7220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078155605 Janssen Pharmaceuticals, Inc $43.31 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082673707 Neos Therapeutics, LP $16.55 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082677955 Neos Therapeutics, LP $22.74 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100152113 Corium, LLC $8.46 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100177004 Corium, LLC $19.75 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101475037 E.R. Squibb & Sons, L.L.C. $19.19 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118939460 Otsuka America Pharmaceutical, Inc. $20.15 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137632807 Takeda Pharmaceuticals U.S.A., Inc. $20.27 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137632809 Takeda Pharmaceuticals U.S.A., Inc. $17.24 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143274921 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.21 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146249437 IRONSHORE PHARMACEUTICALS INC. $20.16 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146301290 IRONSHORE PHARMACEUTICALS INC. $23.85 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146309999 IRONSHORE PHARMACEUTICALS INC. $19.25 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147816692 Supernus Pharmaceuticals, Inc. $14.61 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147816694 Supernus Pharmaceuticals, Inc. $15.47 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147816696 Supernus Pharmaceuticals, Inc. $17.10 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147859735 Supernus Pharmaceuticals, Inc. $18.01 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150823085 Neurocrine Biosciences, Inc. $31.79 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150875206 Neurocrine Biosciences, Inc. $14.97 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151737127 Teva Pharmaceuticals USA, Inc. $21.64 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.